Rights and permissions
About this article
Cite this article
How to overcome ‘double-counting’ in cost-utility analyses. Pharmacoecon. Outcomes News 112, 2 (1997). https://doi.org/10.1007/BF03271590
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271590